FDA Approves First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes; Availability Will Help Increase Access and Potentially Lower the Cost of Insulin for People with Diabetes
Read more: FDA Approves First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes